Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer-Reference-Cited by-同舟云学术

Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer

Published:2018-12-01 Issue:12 Volume:4 Page:1691
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Li Xiangchun¹,Pasche Boris²³,Zhang Wei²³,Chen Kexin⁴

Affiliation:

1. Tianjin Cancer Institute, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China

2. Center for Cancer Genomics and Precision Oncology, Wake Forest Baptist Comprehensive Cancer Center, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina

3. Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, North Carolina

4. Department of Epidemiology and Biostatistics, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Reference22 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.;Ferlay;Int J Cancer,2015

2. Distinct subtypes of gastric cancer defined by molecular characterization include novel mutational signatures with prognostic capability.;Li;Cancer Res,2016

3. Comprehensive molecular characterization of gastric adenocarcinoma.;Cancer Genome Atlas Research Network;Nature,2014

4. Mutational landscape of gastric adenocarcinoma in Chinese: implications for prognosis and therapy.;Chen;Proc Natl Acad Sci U S A,2015

5. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.;Le;Science,2017

Cited by 170 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of a novel histone acetylation-related long non-coding RNA model combined with qRT-PCR experiments for prognosis and therapy in gastric cancer;Heliyon;2024-09

2. Gender and melanoma subtype‐based prognostic implications of MUC16 and TTN co‐occurrent mutations in melanoma: A retrospective multi‐study analysis;Cancer Medicine;2024-09

3. A mutational signature and ARID1A mutation associated with outcome in hepatocellular carcinoma;Clinical and Translational Oncology;2024-08-23

4. The combination of exon sequencing and metabolomics to establish a molecular typing system for gastric cancer;Heliyon;2024-08

5. Construction and validation of a TTN mutation associated immune prognostic model for evaluating immune microenvironment and outcomes of gastric cancer: An observational study;Medicine;2024-07-19